FDA Authorizes Abbott’s '$5, 15 Minute' COVID-19 Antigen Test
The BinaxNOW COVID-19 Ag Card portable lateral flow test, which delivers rapid results with no instrumentation, could be a “game changer” in the effort to reopen schools and other crowded places.
You may also be interested in...
Cue’s point-of-care molecular test earned an FDA emergency use authorization in June.
US Senators said Wednesday coronavirus patients could lose coverage if the ACA is abolished by a new Supreme Court, while Sen. Warren accused a COVID-19 response advisor of conflicts of interest.
The diagnostics company said the test is scheduled for US launch in Q4 2020.